Predictors of Non-response to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study)
不可切除肝细胞癌患者对阿特珠单抗联合贝伐珠单抗治疗无反应的预测因素：一项多中心真实世界研究（HCC-AB 研究）
期刊:Journal of Clinical and Experimental Hepatology
影响因子:3.2
doi:10.1016/j.jceh.2025.102513
Singh, Satender P; Kumar, Karan; Kulkarni, Anand; Arora, Vinod; Choudhury, Ashok; Chaubal, Alisha; Rathi, Sahaj; Shah, Samir; Taneja, Sunil; Kumar, Ashish; Duseja, Ajay; Kumar, Guresh; Nagaraja Rao, P; Saraswat, Vivek; Sarin, Shiv K
